|
For the Three Months
Ended September 30, |
For the Nine Months
Ended September 30, | |||||||||||||||
| 2022 | 2021 | 2022 | 2021 | |||||||||||||
| Non-GAAP Net Loss: | ||||||||||||||||
| Net loss | $ | (15,041 | ) | $ | (14,711 | ) | $ | (51,585 | ) | $ | (37,476 | ) | ||||
| Add (deduct): | ||||||||||||||||
| Depreciation and amortization expense(1) | 1,909 | 816 | 5,716 | 2,304 | ||||||||||||
| Stock-based compensation(2) | 5,113 | 2,266 | 14,048 | 4,747 | ||||||||||||
| Amortization of lease intangible | 333 | — | 999 | — | ||||||||||||
| Amortization of deferred costs on convertible notes | 469 | — | 1,250 | — | ||||||||||||
| Unrealized loss on marketable securities | 469 | 239 | 1,659 | 239 | ||||||||||||
| Acquisition and other (3) | 42 | — | (1,242 | ) | — | |||||||||||
| Loss on sale of property and equipment | — | 10 | 71 | 8 | ||||||||||||
| Charitable contribution of common stock | 987 | 1,157 | 2,272 | 1,157 | ||||||||||||
| Impairment of assets | 325 | — | 444 | — | ||||||||||||
| Non-GAAP Net Loss | $ | (5,394 | ) | $ | (10,223 | ) | $ | (26,368 | ) | $ | (29,021 | ) | ||||
| Weighted-average number of shares outstanding used to compute Non-GAAP Net Loss per share, basic and diluted | 47,303,090 | 43,962,863 | 47,057,521 | 20,092,600 | ||||||||||||
| Non-GAAP EPS, basic and diluted | $ | (0.11 | ) | $ | (0.23 | ) | $ | (0.56 | ) | $ | (1.44 | ) | ||||
Xometry Reports Third Quarter 2022 Results
 |  | More MCAD News
|
|
RELATED NEWS
